H K Kroemer
- Oncology top 10%
- Molecular Biology
- Pharmacology top 1%
- Pediatrics, Perinatology and Child Health top 5%
- Cardiology and Cardiovascular Medicine top 10%
- Co-authors
- Michel EichelbaumUlrich KlotzGerd MikusGabriele JedlitschkyMarkus GrubeThomas E. MürdterStefan OswaldDan M. Roden
- Topics
- Pharmacogenetics and Drug Metabolism (17 papers)Drug Transport and Resistance Mechanisms (9 papers)Pharmaceutical studies and practices (5 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
H K Kroemer
50 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 128
- Oncology 371
- Molecular Biology 337
- Pharmacology 336
- Pediatrics, Perinatology and Child Health 223
- Cardiology and Cardiovascular Medicine 169
Countries citing papers authored by H K Kroemer
This map shows the geographic impact of H K Kroemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H K Kroemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H K Kroemer more than expected).
Fields of papers citing papers by H K Kroemer
This network shows the impact of papers produced by H K Kroemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H K Kroemer. The network helps show where H K Kroemer may publish in the future.
Co-authorship network of co-authors of H K Kroemer
This figure shows the co-authorship network connecting the top 25 collaborators of H K Kroemer. A scholar is included among the top collaborators of H K Kroemer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H K Kroemer. H K Kroemer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 10 | |
| 3 | 31 | |
| 4 | 22 | |
| 5 | 24 | |
| 6 | 17 | |
| 7 | 10 | |
| 8 | 26 | |
| 9 | 30 | |
| 10 | 51 | |
| 11 | 68 | |
| 12 | 2 | |
| 13 | 3 | |
| 14 | 4 | |
| 15 | 1 | |
| 16 | 48 | |
| 17 | 91 | |
| 18 | 48 | |
| 19 | 36 | |
| 20 | 57 |
About H K Kroemer
H K Kroemer is a scholar working on Pharmacology, Oncology and Pharmaceutical Science, having authored 50 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (17 papers), Drug Transport and Resistance Mechanisms (9 papers) and Pharmaceutical studies and practices (5 papers). The work is most often cited by research in Pharmacology (336 citations), Oncology (371 citations) and Pediatrics, Perinatology and Child Health (223 citations). H K Kroemer has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Michel Eichelbaum, Ulrich Klotz, Gerd Mikus, Gabriele Jedlitschky, Markus Grube, Thomas E. Mürdter, Stefan Oswald, Dan M. Roden, Bernhard Sperker and Werner Siegmund. Their work appears in journals such as Circulation, Journal of Clinical Oncology and Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.